Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-005031-17Phase 4
Phase 4, randomised, double-blind trial of Aprol and acetaminophen in primary dysmenorrhea (PD) and dysmenorrhea (2 arms), sponsored by Bayer. Primary endpoint: Sum of Total Pain Relief over 0-12 hours (TOTPAR0-12).
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-005031-17.